FDA developing "regulatory strategy" for cosmetics with drug effects -- CFSAN plan.
This article was originally published in The Rose Sheet
Executive Summary
CFSAN DEVELOPING "REGULATORY STRATEGY" FOR COSMETICS WITH DRUG EFFECTS, according to a strategic plan recently issued by FDA's Center for Food Safety and Applied Nutrition. In the report, CFSAN states that its goal for the agency's cosmetic program is to develop "a regulatory strategy for cosmetic products with pharmacologic components and effects" over the next five to seven years. The "CFSAN Strategic Plan: 1996-2001" outlines the agency's research and regulatory priorities for all products under its purview for the next five years.